Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16,715 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Three-year clinical outcomes of the novel sirolimus-eluting bioresorbable scaffold for the treatment of de novo coronary artery disease: A prospective patient-level pooled analysis of NeoVas trials.
Wang X, Li Y, Fu G, Xu B, Zhou Y, Su X, Liu H, Zhang Z, Yu B, Tao L, Zheng Q, Li L, Xu K, Han Y; NeoVas OPC Investigators. Wang X, et al. Among authors: xu k, xu b. Catheter Cardiovasc Interv. 2023 May;101(6):967-972. doi: 10.1002/ccd.30518. Epub 2023 Mar 7. Catheter Cardiovasc Interv. 2023. PMID: 36881746
Safety and efficacy of the CYPHER Select Sirolimus-eluting stent in the "Real World"--clinical and angiographic results from the China CYPHER Select registry.
Gao RL, Xu B, Lu SZ, Chen JL, Han YL, Chen JZ, Gai LY, Ge JB, Wang WM, Du ZM, Huo Y, Wang LF, Gao W, Chen JY, He B, Jia GL, Yang ZJ, Cao KJ, Li WM, Shen WF, Wan Z, Huang DJ, Zhu GY; CCSR Investigators. Gao RL, et al. Among authors: xu b. Int J Cardiol. 2008 Apr 25;125(3):339-46. doi: 10.1016/j.ijcard.2007.02.031. Epub 2007 Apr 16. Int J Cardiol. 2008. PMID: 17434617
Safety and efficacy of biodegradable polymer-coated sirolimus-eluting stents in "real-world" practice: 18-month clinical and 9-month angiographic outcomes.
Han Y, Jing Q, Xu B, Yang L, Liu H, Shang X, Jiang T, Li Z, Zhang H, Li H, Qiu J, Liu Y, Li Y, Chen X, Gao R; CREATE (Multi-Center Registry of Excel Biodegradable Polymer Drug-Eluting Stents) Investigators. Han Y, et al. Among authors: xu b. JACC Cardiovasc Interv. 2009 Apr;2(4):303-9. doi: 10.1016/j.jcin.2008.12.013. JACC Cardiovasc Interv. 2009. PMID: 19463441 Free article. Clinical Trial.
Thorombolytic therapy with rescue percutaneous coronary intervention versus primary percutaneous coronary intervention in patients with acute myocardial infarction: a multicenter randomized clinical trial.
Gao RL, Han YL, Yang XC, Mao JM, Fang WY, Wang L, Shen WF, Li ZQ, Jia GL, Lü SZ, Wei M, Zeng DY, Chen JL, Qin XW, Xu B, DU CH; Collaborative Research Group of Reperfusion Therapy in Acute Myocardial Infarction (RESTART). Gao RL, et al. Among authors: xu b. Chin Med J (Engl). 2010 Jun;123(11):1365-72. Chin Med J (Engl). 2010. PMID: 20819587 Clinical Trial.
Transradial versus transfemoral method of percutaneous coronary revascularization for unprotected left main coronary artery disease: comparison of procedural and late-term outcomes.
Yang YJ, Kandzari DE, Gao Z, Xu B, Chen JL, Qiao SB, Li JJ, Qin XW, Yao M, Wu YJ, Yuan JQ, Chen J, Liu HB, Dai J, Chen T, Wang Y, Li W, Gao RL. Yang YJ, et al. Among authors: xu b. JACC Cardiovasc Interv. 2010 Oct;3(10):1035-42. doi: 10.1016/j.jcin.2010.09.003. JACC Cardiovasc Interv. 2010. PMID: 20965462 Free article.
A prospective multicenter parallel-controlled trial of TIVOLI biodegradable-polymer-based sirolimus-eluting stent compared to ENDEAVOR zotarolimus-eluting stent for the treatment of coronary artery disease: 8-month angiographic and 2-year clinical follow-up results.
Xu B, Dou KF, Han YL, Lü SZ, Yang YJ, Huo Y, Wang LF, Chen YD, Wang HC, Li WM, Chen JY, Wang L, Wang Y, Ge JB, Li W, Gao RL. Xu B, et al. Chin Med J (Engl). 2011 Mar;124(6):811-6. Chin Med J (Engl). 2011. PMID: 21518585 Clinical Trial.
16,715 results
You have reached the last available page of results. Please see the User Guide for more information.